XARELTO® is a renowned brand that offers a highly effective blood thinner called rivaroxaban. Designed to treat and prevent blood clots associated with various heart and blood vessel conditions, XARELTO® is a game-changer in the medical field. Unlike traditional blood-thinning medications, XARELTO® belongs to a category known as DOACs (direct oral anticoagulants), which specifically target Factor Xa (10a).

These innovative medications have fewer effects on factors that contribute to blood clot formation. There are two main types of blood thinners: antiplatelets and anticoagulants. While antiplatelets prevent platelets in the blood from sticking together and forming clots, anticoagulants, such as XARELTO®, lower the blood's clotting ability.

By inhibiting Factor Xa, XARELTO® significantly reduces the risk of blood clot formation. XARELTO® offers a comprehensive range of products and services for various conditions, including Nonvalvular Atrial Fibrillation (AFib), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD), Knee and Hip Replacement, and Pediatric DVT/PE. With XARELTO®, patients can find the support, safety, and peace of mind they need to live a healthy and fulfilling life